Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 223.29 billion as of April 17, 2025. Its market cap has increased by 105.81% in one year.

Market Cap

223.29B

Enterprise Value

339.19B

Revenue

67.38B

Ranking

n/a

PE Ratio

n/a

Stock Price

715.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 223.29B, an increase of 6,920.51%. That is a compound annual growth rate of 15.61%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2025	223.29B	70.72%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.81T
Celltrion	34.26T
ALTEOGEN	19.53T
Yuhan	8,492.29B
SK Biopharmaceuticals	8,034.94B
HLB Co., Ltd.	7,133.40B
LigaChem Biosciences	3,795.10B
PharmaResearch	3,735.08B

Market Cap Rankings